Blog
According to the CDC, COVID-19’s death rate has increased year after year. And from 2021 to 2022, it’s become the third leading cause of death in the United States after heart disease and cancer.
While it hasn’t been declared a variant of concern, the Centers for Disease Control and Prevention (CDC) is concerned about the transmissibility of the most recent COVID-19 variant, the Omicron BA.2.
Continue reading
Researchers in Hong Kong studied the severity of the BA.2 variant among a small number of children who were hospitalized for the most recent COVID-19 strain. They found that children who were hospitalized with the BA.2 variant were 18 times more likely to be admitted to the ICU and seven times more likely to die compared to those hospitalized with the flu.
BA.2 accounts for the majority of U.S. COVID-19 cases and because of its high transmissibility risk, health authorities predict a new surge is coming. While we only have a partial picture of what’s to come with BA.2, health officials are watching out for three signs of a new surge.
Continue reading
There are many drugs surfacing as effective treatments for COVID-19 but are not backed by research, clinical trials, or authorization from the U.S. FDA. Some physicians are aiming to shed light on false information on unproven COVID-19 treatments and stop their use in healthcare settings.
Continue reading
